On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy.
Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Kno...
On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy.
Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast.
Segment 1 – AI & the Future of Medical Information with Nested Knowledge
Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information.
Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights.
Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes
Next, we’re joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing.
Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models.
Segment 3 – Emerging Therapies with Cardinal Health
In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare.
Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement.
About TWIRx (This Week in Pharmacy)
TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.
